The OLYMPUS Study - Optimized DeLivery of Mitomycin for Primary UTUC Study

Clinical trial NCT02793128 · COMPLETED

Trial details

NCT number: NCT02793128
Sponsor: UroGen Pharma Ltd.
Status: COMPLETED
Phase: Phase 3
Study type: INTERVENTIONAL

Carcinoma, Transitional Cell Transitional Cell Carcinoma of Renal Pelvis

Start date: 2017-04-04
Primary completion: 2019-04-05
Enrollment: 71

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.